<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>Untitled Document</title>
<link href="../js/main.css" rel="stylesheet" type="text/css" />
<link href="../js/images.css" rel="stylesheet" type="text/css" />
</head>



<body style="width:500px; margin:auto"><br />
<br />




<div style="font-family:Arial; color:#58585a; font-size:11pt">
<div style="padding:10px; background-color:#ad9565; border:#534730 2px solid; color:#534730; font-weight:400; font-family:Arial;">
Please read <a href="http://www.kidswithfoodallergies.org/resources/resourceshow.php?id=124" style="color:#ECDBC4"><strong>Frequently  Asked Questions about Food Allergens in Vaccines</strong></a> to put the information presented here about vaccine ingredients into context.
<br />
<br />
<strong>Disclaimer:</strong> The following tables are presented for informational  purposes only and are not meant to replace the advice of your health care  professionals.<br /><br />
Also note that under &quot;Contraindications&quot;, several sources are listed, which may not all agree  with one another. Some contraindications are considered <em>absolute</em> (applicable under all circumstances), while other  contraindications may be considered <em>relative</em> (applicable in specific or certain   cases). The package insert information for each specific product is meant  to give the broadest protection for not only the patient, but for the drug  company as well. <br /></div>


<br />
<br />
<a name="top" id="top"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Ingredients, Contraindications and Comments for Vaccines for Children 7-18 Years Old
</h2><br />

<a href="#combo"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Combination Vaccines</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#twin" style="color: #1C98D5">Twinrix&reg; / Hepatitis A inactivated, Hepatitis B recombinant </a><br />
<br />
<a href="#dip"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Diphtheria, Tetanus, Pertussis</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#adacel" style="color: #1C98D5">Adacel&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#boostrix" style="color: #1C98D5">Boostrix&reg;</a><br />
<br />



<a href="#hepa"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Hepatitis A, inactivated</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#vaqta" style="color: #1C98D5">Vaqta&reg;&nbsp;&nbsp;Ped/Adol formulation</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#havrix" style="color: #1C98D5">Havrix&reg;</a><br />
<br />

<a href="#hepb"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Hepatitis B</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#engerix" style="color: #1C98D5">Engerix-B&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#recom" style="color: #1C98D5">Recombivax HB&reg;</a><br />
<br />
<a href="#human"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Human Papillomavirus Quadrivalent</strong></a><br />


&nbsp;&nbsp;&nbsp;&nbsp;<a href="#cervarix" style="color: #1C98D5">Cervarix&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#gardasil" style="color: #1C98D5">Gardasil&reg;</a><br />
<br />
<a href="#influenza"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Influenza, inactivated, injectable (TIV)</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#afluria" style="color: #1C98D5">Afluria&reg; (2010-11)</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#fluarix" style="color: #1C98D5">Fluarix&reg; (2010-11)</a><br />

&nbsp;&nbsp;&nbsp;&nbsp;<a href="#fluvirin" style="color: #1C98D5">Fluvirin&reg; (2010-11)</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#fluzone" style="color: #1C98D5">Fluzone&reg; (2010-11)</a><br />
<br />
<br />
<a href="#laiv"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Influenza Virus Live Intranasal (LAIV)</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#flumist" style="color: #1C98D5">FluMist&reg; &nbsp;Intranasal Spray (2010-11)</a><br />
<br />
<br />
<a href="#measles"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Measles, Mumps, Rubella (MMR)</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#m-m" style="color: #1C98D5">M-M-R II&reg;</a><br />
<br />
<a href="#menin"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Meningococcal</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#menactra" style="color: #1C98D5">Menactra&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#menomune" style="color: #1C98D5">Menomune&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#menveo" style="color: #1C98D5">Menveo&reg;</a><br />
<br />
<a href="#pneumococcal"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Pneumococcal</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#pneumovax" style="color: #1C98D5">Pneumovax 23&reg; (PPV)</a><br />

<br />
<a href="#pol"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Poliovirus, inactivated</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#ipol" style="color: #1C98D5">Ipol&reg;</a><br />
<br />

<a href="#tetanus"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Tetanus &amp; Diphtheria Toxoids</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#deca" style="color: #1C98D5">Decavac&reg;</a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#generictd" style="color: #1C98D5">Generic*</a><br />

<br />

<a href="#varicella"  style="color:#00719a; text-transform:uppercase; font-family:Arial;"><strong>Varicella (Chickenpox)</strong></a><br />
&nbsp;&nbsp;&nbsp;&nbsp;<a href="#varivax" style="color: #1C98D5">Varivax&reg;</a><br />
<br />
  

 <a name="combo" id="combo"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Combination Vaccines</h2><br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="comvax" id="twin"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"> <strong>Twinrix&reg;</strong> Hepatitis A inactivated, Hepatitis B recombinant </div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left"> GlaxoSmithKline<br />
        <a href="http://www.gskvaccines.com" target="_blank">www.gskvaccines.com</a><br />
        866-GSK-VACC </div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td> Aluminum phophate, aluminum hydroxide, amino acids, sodium chloride, phophate buffer, polysorbate 20, formalin &lt;0.1 mg, residual MRC-5 cellular protiens, neomycin &lt;20 ng, no more than 5% yeast proteins, no preservatives.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Hepatitis A: MRC-5 cells<br />
<br />
Hepatitis B: S. cerevisiae cells in synthetic media</p></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>
  <td>Hypersensitivity to any component of the vaccine, including yeast and neomycin; hypersensitivity to monovalent Hepatitis A or Hepatitis B vaccines.<sup>1</sup> </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>For persons 18 years of age and older. Contains the same antigenic components as <a href="#havrix">Havrix&reg;</a> and <a href="#engerix">Engerix-B&reg;</a>.<br />
<br />
The tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber. The vial stopper is latex-free.<sup>1</sup> </td>  
  </tr></table>

<a href='#top'>Back to Top</a><br /><br /><br />
<br />
<a name="dip" id="dip"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Diphtheria, Tetanus, Pertussis </h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="adacel" id="adacel"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong> Adacel&reg;</strong> (Tdap)</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td>Sanofi Pasteur<br />
      <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
800-822-2463</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td>Aluminum phosphate, &lt;5 mcg formaldehyde, &lt;50 ng glutaraldehyde,   3.3 mg  2-phenoxyethanol (not as preservative), sterile water.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Pertussis: Stainer-Scholte medium modified by added casamino acids and dimethyl-beta-cyclodextrin.<br /><br />
  Diphtheria: Modified Mueller's growth medium.<br />
  <br />
  Tetanus: Modified Mueller-Miller casamino acid medium without beef heart infusion.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td> Severe allergic reaction to any component of the vaccine - because of the uncertainty as to which component of the vaccine may be responsible, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered; encephalopathy within 7 days of a previous pertussis- containing vaccine not attributable to another identifiable cause. <sup>1</sup><br />
<br />
Progressive neurologic disorder, uncontrolled epilepsy, or progressive encephalopathy, until a treatment regimen has been established and the condition stabilized .  <sup>2(92)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>For ages 11-64; contains same antigens as <a href="http://kidswithfoodallergies.org/resources/resourceshow.php?id=127#daptacel" target="_blank">Daptacel&reg;</a>, however formulated with reduced quantities of Diphtheria Toxoid and Detoxified Pertussis Toxin.<br />
<br />
The vial stopper is latex-free.</p></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="boostrix" id="boostrix"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Boostrix&reg;</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td>GlaxoSmithKline Biologicals<br />
      <a href="http://www.gsk.com" target="_blank">www.gsk.com</a><br />
888-825-5249</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td>Sodium chloride, aluminum hydroxide, &lt;100 mcg formaldehyde, &lt;100 mcg polysorbate 80, no preservative.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    
  <td>Pertussis: Modified Stainer-Scholte liquid medium.<br />
    <br />
    Diphtheria: Fenton medium containing a bovine extract.<br />
    <br />
    Tetanus: Modified Latham medium derived from bovine casein.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td> Severe allergic reaction to any component of the vaccine - because of the uncertainty as to which component of the vaccine might be responsible, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered; encephalopathy within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause; progressive neurological disorder until a treatment regimen has been established and the condition stabilized.<sup>1</sup><br />
    </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>For ages 10-18; contains the same antigens as <a href="http://kidswithfoodallergies.org/resources/resourceshow.php?id=127#infanrix" target="_blank">Infanrix&reg;</a>, but formulated with reduced quantities of these antigens.<br />
<br />


The tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber, while the vial stopper is latex-free.<sup>1</sup></td>  
  </tr></table>
<a href='#top'>  Back to Top</a><br />
<br />





<a name="hepa" id="hepa"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Hepatitis A, inactivated</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="vaqta" id="vaqta"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Vaqta&reg;</strong> Ped/Adol formulation</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Merck Vaccine Division<br />
        <a href="http://www.merckvaccines.com" target="_blank">www.merckvaccines.com</a><br />
800-525-2065</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Aluminum hydroxyphophate sulfate, sodium borate, saline, &lt;10<sup>-4</sup> mcg bovine albumin, &lt;0.8 mcg formaldehyde, no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>MRC-5 human diploid cell culture.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Hypersensitivity to any component of the vaccine; should not be administered with a history of severe reaction to a prior dose of Hepatitis A vaccine nor to a vaccine component.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Vial stopper and syringe plunger stopper contain dry natural latex rubber.<sup>1</sup></td>  
  </tr></table>
<a href='#top'> Back to Top</a><br />
<br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="havrix" id="havrix"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Havrix&reg;</strong></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">GlaxoSmithKline<br />
        <a href="http://www.havrix.com" target="_blank">www.havrix.com</a><br />
      888-825-5249</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Aluminum hydroxide, amino acid supplements (0.3%) in a phophate buffered saline solution, polysorbate 20, residual formalin &lt;0.1 mg/ml, neomycin sulfate &lt;40 ng/ml; aminoglycoside antibiotic included in the cell growth media, no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>MRC-5 human diploid cells.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis A containing vaccine or to any component of vaccine, including neomycin.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber. The vial stopper is latex-free.<sup>1</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />

<a name="hepb" id="hepb"></a><h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Hepatitis B</h2><br />

 
    
  <table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="engerix" id="engerix"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Engerix-B&reg;</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td>GlaxoSmithKline Biologicals<br />
      <a href="http://www.gsk.com" target="_blank">www.gsk.com</a><br />
      888-825-5249</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td>Pediatric/adolescent formulation: aluminum hydroxide, sodium chloride, disodium phosphate dihydrate, sodium dihydrogen phophate dihydrate</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Yeast cells</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Hypersensitivity to any component of the vaccine, including yeast. <sup>1</sup><br /><br />Relative contraindication in patients with history of hypersensitivity to yeast. <sup>2(195)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Contains no more than 5% yeast; vial stoppers latex-free; tip cap and rubber plunger of needleless prefilled syringes contain dry natural latex rubber.<sup>1</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="recom" id="recom"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Recombivax HB&reg;</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td>Merck Vaccine Division<br />
      <a href="http://www.merckvaccines.com" target="_blank">www.merckvaccines.com</a><br />
800-525-2065</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td>Aluminum hydroxyphosphate sulfate; preservative-free</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Yeast cells</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Hypersensitivity to any component of the vaccine, including yeast. <sup>1</sup><br /><br />Relative contraindication in patients with history of hypersensitivity to yeast. <sup>2(195)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>May contain not more than 1% yeast protein; latex present in vial stopper. <sup>1</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br /><a name="human" id="human"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Human Papillomavirus Quadrivalent</h2><br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="cervarix" id="cervarix"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Cervarix&reg;</strong> Bi-valent HPV2</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td> GlaxoSmithKline<br />
      <a href="http://www.gsk.com" target="_blank">www.gsk.com</a><br />
      800-525-2065 </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td>Each dose contains 0.5 mg aluminum hydroxide, 4.4 mg sodium chloride, 0.624 mg sodium    dihydrogen phosphate dihydrate; may contain residual amounts of insect cell    and viral protein (&lt;40 ng), bacteria cell protein (&lt;150 ng) from the    manufacturing process.</td>

  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    
  <td>Serum free culture media (ASO4) of chemically defined lipids, vitamins, amino acids and mineral salts; replication occurs in Trichoplusia ni insect cells, then purified and absorbed on aluminum hydroxide salts. </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td> Severe allergic reaction to any  component of the vaccine.<sup>1</sup><br />
    </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td> Indicated for females, 10 through 25 years of age. Not recommended for use in pregnancy.  Does not contain a preservative.<br />
    <br />
    The tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber. The stopper of the vial does not contain latex.<sup>1</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="gardasil" id="gardasil"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Gardasil&reg;</strong> Quadrivalent</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td> Merck Vaccine Division<br />
      <a href="http://www.gardasil.com" target="_blank">www.gardasil.com</a><br />
      800-525-2065 </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td> Amorphous aluminum hydroxyphosphate sulfate, sodium chloride, L-histidine, polysorbate 80, sodium borate, &lt;7 mcg yeast protein per dose,  water for injection; does not contain a preservative nor antibiotics.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    
  <td> S. cerevisiae (budding yeast) on chemically defined fermentation media which includes vitamins, amino acids, mineral salts, and carbohydrates. </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td> Hypersensitivity to the active substances or to any of the excipients; individuals who develop symptoms indicative of hypersensitivity after receiving a dose should not receive further doses of the vaccine.<sup>1</sup><br />
    </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td> Indicated in females and males 9-26 years of age. Not for use in pregnancy. </td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="influenza" id="influenza"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Influenza, inactivated, injectable (TIV)</h2><br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'>
  <tr>
    <td width='41%' valign='top'><div align='right'><strong><a name="afluria" id="afluria"></a>Brand Name:</strong></div></td>
    <td width='59%'><strong>Afluria&reg; (2010-2011)</strong> </td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Company:</strong></div></td>
    <td> CSL Limited<br />
<a href="http://www.csl.com.au" target="_blank">www.csl.com.au</a><br />
</td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
      (per dose)</strong></div></td>
    <td>Each 0.5 ml dose contains sodium chloride 4.1 mg, monobasic sodium phosphate 80 mcg, dibasic sodium phophate 300 mcg, monobasic potassium phophate 20 mcg, potassium chloride 20 mcg, and calcium chloride 1.5 mcg. From the manufacturing process, each dose may contain residual amounts of sodium taurodeoxycholate &lt;10 ppm, ovalbumin &lt;1 mcg, neomycin sulfate &lt;0.2 pg, polymixin B &lt;0.03 pg, and beta-propriolactone &lt;25 ng.<sup>1</sup></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>
    <td> Allantoic fluid of embryonated chicken eggs.</td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>
    <td> Hypersensitivity to eggs, neomycin, or polymixin, or life-threatening reaction to previous influenza vaccine.<sup>1</sup><br />
      <br />
      The FDA  includes the contraindication of vaccination of persons with a history of Guillain-Barre Syndrome (GBS), but it is not included in the ACIP recommendations. The ACIP believes that the benefits of influenza immunization justify annual vaccination, but cautions not to administer the vaccine within 6 weeks of GBS. <sup>2(208), 5</sup></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>
    <td>  The CDC has recommended that this particular vaccine not be routinely administered to children aged 6 months through 8 years.<sup>9</sup><br />
<br />
 The multi-dose vial contains thimerosal as a preservative - each 0.5 ml dose contains 24.5 mcg of mercury. The single-dose syringe formulation is preservative-free.<sup>1</sup><br />
      <br />The rubber tip cap and plunger used for the single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.<sup>1</sup><br /></td>
  </tr>
</table>
<a href='#top'>Back to Top</a><br />
<br />
<br />
<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'>
  <tr>
    <td width='41%' valign='top'><div align='right'><strong><a name="fluarix" id="fluarix"></a>Brand Name:</strong></div></td>
    <td width='59%'><strong>Fluarix&reg; (2010-2011)</strong></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Company:</strong></div></td>
    <td> GlaxoSmithKline<br />
      <a href="http://www.gsk.com" target="_blank">www.gsk.com</a><br />
      888-825-5249      <br /></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
      (per dose)</strong></div></td>
    <td>Each 0.5 ml dose also contains octoxynol-10 &lt;0.085 mg, alpha tocopheryl hydrogen succinate &lt;0.1 mg, and polysorbate 80 &lt;0.415 mg.<br />
      <br />
      Each dose may also contain residual amounts of hydrocortisone &lt;0.0016 mg, gentamicin sulfate &lt;0.15 mcg, ovalbumin &lt;0.05 mcg, formaldehyde &lt;5 mcg, and sodium deoxycholate &lt;50 mcg from the manufacturing process.      <sup>1</sup></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>
    <td> Propagated in embryonated chicken eggs.</td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>
    <td> History of systemic hypersensitivity reactions to egg proteins, or any other component of this vaccine or life-threatening reactions to previous influenza vaccinations.<sup>1</sup><br />
      <br />
      The FDA  includes the relative contraindication of vaccination of persons with a history of Guillain-Barre Syndrome (GBS), but it is not included in the ACIP recommendations. The ACIP believes that the benefits of influenza immunization justify annual vaccination, but cautions not to administer the vaccine within 6 weeks of GBS. <sup>2(208), 5</sup></td>
  </tr>
  <tr>
    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>
    <td> The tip caps of the prefilled syringes may contain natural rubber latex. The rubber plungers do not contain latex.<sup>1</sup><br /></td>
  </tr>
</table>
<a href='#top'>Back to Top</a><br />
<br />
<br />
<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="fluvirin" id="fluvirin"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Fluvirin&reg; (2010-2011)</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td>An affiliate of Novartis Vaccines &amp; Diagnostics Limited<br />
      <a href="http://www.novartisvaccines.com" target="_blank">www.novartisvaccines.com</a><br />
      800-244-7668</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td>Phosphate buffered saline, residual amounts of egg proteins ( &lt;1 mcg ovalbumin), polymixin &lt;3.75 mcg, neomycin &lt;2.5 mcg, betapropiolactone &lt;0.5 mcg, and nonylphenol ethoxylate (&lt;0.015% w/v).<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Prepared in the allantoic cavity of embryonated hens' eggs.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>History of systemic hypersensitivity reactions to egg proteins, or any other component of this vaccine or life-threatening reactions to previous influenza vaccinations.<sup>1</sup><br /><br />
    The FDA  includes the relative contraindication of vaccination of persons with a history of Guillain-Barre Syndrome (GBS), but it is not included in the ACIP recommendations. The ACIP believes that the benefits of influenza immunization justify annual vaccination, but cautions not to administer the vaccine within 6 weeks of GBS.<sup>2(208), 5</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>The tip caps of the prefilled syringes may contain natural rubber latex. The multi-dose vial stopper and the syringe stopper/plunger do  not contain latex.<sup>1</sup><br />
    <br /> 
    The 0.5 ml prefilled syringe contains a trace amount of thimerosal, &lt;1 mcg mercury. The 5 ml multi-dose vial contains thimerosal, 25 mcg per 0.5 ml dose. <sup>1</sup></td>  
  </tr></table>
<a href='#top'>
Back to Top</a><br />
<br /><br />
<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="fluzone" id="fluzone"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Fluzone&reg; (2010-2011)</strong> </div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Sanofi Pasteur<br />
        <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
800-822-2463</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Sodium phosphate buffered isotonic saline. No antibiotics are used in the manufacturing process. <sup>1</sup></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Propagated in embryonated chicken eggs. Sucrose, octylphenol ethoxylate, and formaldehyde are also used in the process.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Known hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after a previous administration of any influenza vaccine.<sup>1</sup><br />
<br />

      The FDA and manufacturer include the relative contraindication of vaccination of persons with a history of Guillain-Barre Syndrome (GBS), but it is not included in the ACIP recommendations. The ACIP believes that the benefits of influenza immunization justify annual vaccination, but cautions not to administer the vaccine within 6 weeks of GBS.<sup>2(208), 5</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>The 0.25 ml prefilled syringes, the 0.5 ml prefilled syringe, and the single dose vial (0.5 ml) contain no preservatives. The 5 ml multi-dose vial contains thimerosal (25 mcg/dose).<sup>1</sup><br />
    <br />
    The tip caps of the prefilled syringes may contain natural rubber latex.<sup>1</sup><br />
<br />
There is no evidence that patients with allergies to chickens or feathers are at an increased risk of reaction to the vaccine.<sup>2 (208)</sup></td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />

<a name="laiv" id="laiv"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Influenza Virus Live Intranasal (LAIV)</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="flumist" id="flumist"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>FluMist&reg; Intranasal Spray (2010-2011)</strong></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">MedImmune Vaccines, Inc.<br />
        <a href="http://www.medimmune.com" target="_blank">www.medimmune.com</a><br />
      877-633-4411</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">0.188 mg/dose monosodium glutamate, 2.00 mg/dose hydrolyzed porcine gelatin, 2.42 mg/dose arginine, 13.68 mg/dose sucrose, 2.26 mg/dose dibasic potassium phosphate, 0.96 mg/dose monobasic potassium phophate, and &lt;0.015 mcg/ml gentamicin sulfate.<sup>1</sup></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Allantoic fluid of eggs.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Contraindicated with history of hypersensitivity reactions to eggs, egg proteins, gentamicin, gelatin, arginine, life-threatening reactions to previous influenza vaccines, in children and adolescents (2-17 years old) receiving aspirin therapy or aspirin.<sup>1</sup><br />
<br />
Relative contraindications include a history of asthma or reactive airway disease, history of Guillan-Barre syndrome, known or suspected immune deficiency diseases, immunosuppression by various therapies, certain metabolic diseases, sickle cell disease.<sup>2(218),4(249)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Contains no preservative. Indicated for individuals 2-49 years of age.<sup>1</sup><br />
    <br />
    The single use nasal sprayer contains no latex.<sup>1</sup></td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="measles" id="measles"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Measles, Mumps, Rubella (MMR)</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="m-m" id="m-m"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>M-M-R II&reg;</strong></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Merck Vaccine Division<br />
        <a href="http://www.merckvaccines.com" target="_blank">www.merckvaccines.com</a><br />
800-525-2065</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Sorbitol, sodium phophate, sucrose, sodium chloride, hydrolyzed gelatin, recombinant human albumin, fetal bovine serum, neomycin, no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Measles and mumps: Chicken embryo cell and Medium 199 with sucrose, phophate, glutamate, recombinant human albumin,  fetal bovine serum, and neomycin.<br />
<br />
Rubella:  Human diploid lung fibroblasts, Minimum Essential Medium with fetal bovine serum, recombinant human albumin, neomycin, sorbital and hydrolyzed gelatin stabilizer.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Hypersensitivity to any component of the vaccine, including gelatin; anaphylaxis to  neomycin; acute febrile respiratory illnesses or other active febrile illness; active immunosuppressive therapy (except replacement corticosteroid therapy); blood dyscrasias, leukemia, lymphoma or other malignant neoplasms affecting bone marrow or lymphatic systems; primary and acquired immunodeficiency states; and family history of congenital or hereditary immunodeficiency. <br />
        <br />
    The AAP has stated, &quot;Most children with a history of anaphylactic reactions to eggs have no untoward reactions to measles or MMR vaccine. Persons are not at increased risk if they have egg allergies that are not anaphylactic, and they should be vaccinated in the usual manner. In addition, skin testing of egg-allergic children with vaccine has not been predictive of which children will have an immediate hypersensitivity reaction...Persons with allergies to chickens or chicken feathers are not at increased risk of reaction to the vaccine.&quot;<sup>1</sup><br />
<br />
Active untreated tuberculosis.<sup>2 (235)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Similar, but not exact vaccines are Priorix&reg; (GlaxoSmithKline - Australia), Tresivac&reg; (Serum Institute of India, Ltd), Trimovax&reg; (Sanofi Pasteur - Europe).</td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="menin" id="menin"></a><h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Meningococcal</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="menactra" id="menactra"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Menactra&reg;</strong> (MCV4)</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Sanofi Pasteur<br />
        <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
      800-822-2463</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Sodium phosphate buffered isotonic sodium chloride solution, no preservative</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    
  <td>N. meningitidis: cultured on Mueller-Hinton agar and grown in Watson-Scherp media. C. diphtheriae: grown in modified Mueller and Miller medium.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Known hypersensitivity to any component of the vaccine including diphtheria toxoid or a life-threatening reaction after previous administration of a vaccine containing similar components; known history of Guillain-Barre syndrome.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>The stopper of the vial contains dry natural rubber latex. The syringe is latex-free.<sup>1</sup><br />
<br />
Of the two meningococcal vaccines, this is the preferred version in the US.</td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="menomune" id="menomune"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Menomune&reg;</strong> (MPSV, MPV4)</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Sanofi Pasteur<br />
        <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
800-822-2463</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Powder contains 2.5 to 5 mg lactose per 0.5 ml. multi-dose 10 ml vial diluent contains 0.01% thimerosal, but single dose vial has no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Casamino acid medium and medium 199.  N. meningitidis are cultivated with Mueller Hinton agar and Watson Scherp media.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Severe anaphylactic reaction to a vaccine component or following a prior dose of vaccine.<sup>4 (280)</sup><br />
<br />
Defer immunization during the course of any acute illness.<sup>2 (131)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>The stopper to the 10 ml vial contains dry natural latex rubber.<br />
<br />
May be used when <a href="#menactra">Menactra®</a> is not available.</td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="menveo" id="menveo"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Menveo&reg;</strong> (MCV4)</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Novartis Vaccines &amp; Diagnostics<br />
        <a href="http://www.novartisvaccines.com" target="_blank">www.novartisvaccines.com</a><br />
800-244-7668</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">The diluent containing three of the serogroups conjugated to CRM 197 is in 0.5 ml of phosphate buffered saline. The fourth group is in a lyophylized (dried) state.<sup>7</sup> Contains no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>N. meningitidis; cultured and grown on Franz Complete medium, treated with formaldehyde. C. diphtheriae; cultured and grown on CY medium containing yeast extracts and amino acids. <sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Severe allergic reaction after a previous dose of Menveo&reg;, any component of this vaccine, or any other CRM 197 diphtheria toxoid or meningococcal-containing vaccine. <sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>The serogroups are the same as in <a href="#menactra">Menactra&reg;</a>.<br />
<br />
For persons 11 to 55 years of age.</td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="pneumococcal" id="pneumococcal"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Pneumococcal</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="pneumovax" id="pneumovax"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Pneumovax 23&reg;</strong> (PPV)</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Merck Vaccine Division<br />
        <a href="http://www.merckvaccines.com" target="_blank">www.merckvaccines.com</a><br />
      800-525-2065</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">0.25% phenol as preservative, sterile saline</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    
  <td>Media containing bovine proteins.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>Hypersensitivity to any component of the vaccine.<sup>1</sup><br />
<br />
Patients with a history of any type of neurological sign or symptom following administration of vaccine.<sup>2(158)</sup> </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>May be indicated in some individuals older than 2 years with certain medical problems.</td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="pol" id="pol"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Poliovirus, inactivated</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="ipol" id="ipol"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Ipol&reg;</strong></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Sanofi Pasteur<br />
        <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
800-822-2463</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Phosphate buffered saline, 0.5% 2-phenoxyethanol, &lt;0.02% formaldehyde, trace amounts of neomycin, streptomycin, and polymyxin B, &lt;1 ppm newborn calf serum.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Monkey kidney cells, Vero; Eagle MEM modified medium, M-199 medium</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>History of hypersensitivity to any component of vaccine, including 2-phenoxyethanol, formaldehyde, neomycin, streptomycin, and polymyxin B. If anaphylaxis or anaphylactic shock occurs within 24 hours of administration, give no further doses.<sup>1, 2(272)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Needle cover of syringe contains dry natural latex rubber, but no latex in the vial stopper nor plunger of the syringe.</td>  
</tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<a name="tetanus" id="tetanus"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Tetanus &amp; Diptheria Toxoids</h2><br />

<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="deca" id="deca"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Decavac&reg;</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td> Sanofi Pasteur<br />
      <a href="http://www.sanofipasteur.us" target="_blank">www.sanofipasteur.us</a><br />
      800-822-2463 </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    
  <td> Aluminum potassium sulfate, bovine extract, formaldehyde or formalin (&lt;0.02%), 2-phenoxyethanol, trace thimerosal. Depending on formulation may contain glycine, sodium acetate, sodium phophate, aluminum chloride, hydrochloric acid and/or sodium hydroxide.<sup>2(104), 4(B-14)</sup> </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td><p>Diphtheria: Mueller growth media<br />
<br />
Tetanus: Modified Mueller-Miller media, peptone based containing bovine extract.</p></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td> History of serious adverse reaction to any component of this product.<sup>2(101)</sup><br />
    <br />While acute infection may be a reason for deferring routine immunizations, it is not a reason to withhold emergency doses.</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>For use after the age of 7 years. The stopper of the vial and the Luer-Lok 0.5 ml syringes do not contain latex. The syringes are preservative-free.<sup>4(B-16)</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="generictd" id="generictd"></a>Brand Name:</strong></div></td>    
 <td width='59%'><strong>Tetanus and Diptheria Toxoids (Generic)*</strong></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td> Mass. Biological Laboratories<br />
    508-856-2000 </td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td> Aluminum hydroxide, aluminum phosphate formaldehyde or formalin, thimerosal (some multi-dose containers).<sup>4(B-14)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Diphtheria: Mueller growth media.<br />
<br />


Tetanus: Modified Mueller-Miller media, peptone based containing bovine extract.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td><p>History of serious adverse reaction to any component of this product.<sup>2(101)</sup><br />
<br />
While acute infection may be a reason for deferring routine immunizations, it is not a reason to withhold emergency doses.<sup>2(101)</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td> For use after the age of 7 years. The stopper of the vial as well as syringes may contain dry natural latex rubber.<sup>1</sup> <br />
    <br />
    *Other generic versions may be available. Read the accompanying package insert to determine all ingredients.</td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />

<a name="varicella" id="varicella"></a>
<h2 style="color:#00719a; text-transform:uppercase; font-family:Arial;">Varicella (Chickenpox)</h2><br />


<table width='500' style='border:#aae0fa 2px solid;'cellspacing='2' cellpadding='5'><tr>    <td width='41%' valign='top'><div align='right'><strong><a name="varivax" id="varivax"></a>Brand Name:</strong></div></td>    
 <td width='59%'><div align="left"><strong>Varivax&reg;</strong></div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Company:</strong></div></td>    <td><div align="left">Merck Vaccine Division<br />
        <a href="http://www.merckvaccines.com" target="_blank">www.merckvaccines.com</a><br />
800-525-2065</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Inactive Ingredients: <br />
  (per dose)</strong></div></td>    <td><div align="left">Sucrose, hydrolyzed gelatin (porcine), sodium chloride, monosodium L-glutamate, sodium phosphate dibasic, potassium phosphate monobasic, potassium chloride, residual components of MRC-5 cells including DNA and protein; and trace quantities of sodium phosphate monobasic, EDTA, neomycin, and fetal bovine serum; no preservative.</div></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Vaccine-Production Media:</strong></div></td>    <td>Human diploid cell culture.</td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Contraindications To Use:</strong></div></td>    <td>History of hypersensitivity to any component of the vaccine, including gelatin; history of anaphylactoid reaction to neomycin; individuals with blood dyscrasias, leukemia, lymphoma of any type, or other malignant neoplasms affecting the bone marrow or lymphatic system; individuals receiving immunosuppressive therapy, individuals with primary and acquired immunodeficiency states; family history of congenital or hereditary immunodeficiency;  active untreated tuberculosis; and any febrile respiratory illness or other active febrile infection.<sup>1</sup></td>  
  </tr>  <tr>    <td valign='top'><div align='right'><strong>Comments:</strong></div></td>    
  <td>Vaccination should be deferred for at least 5 months following blood or plasma transfusions, or administration of immune globulin.<sup>1 <br />
    <br />
  </sup>The ACIP recommendations state that neomycin allergy is usually of the contact dermatitis type, which is a delayed immune response rather than anaphylaxis. Therefore a history of contact dermatitis to neomycin  is not a contraindication to receiving varicellar vaccines.<sup>5</sup></td>  
  </tr></table>
<a href='#top'>Back to Top</a><br /><br /><br />
<br />
<br />



<div align="center" style="font-family:Arial; color:#58585a; font-size:10pt;"><strong>References for Excipients in Vaccines Tables</strong></div>

<blockquote  style="font-family:Arial; color:#58585a; font-size:10pt;">
  1. Individual  product package insert<br />
<br />

 2. Grabenstein,  John D., <u>ImmunoFacts:  Vaccines and Immunologic Drugs 2007.</u> St.  Louis,        MO: Wolters Kluwer Health,  2006<br />
<br />
3. The   Children's Hospital of Philadelphia, Vaccine Education        Center, &ldquo;Hot Topic:  Gelatin Allergies&rdquo; accessed 5/08/2010, <a href="http://www.chop.edu/service/vaccine-education-center/hot-topics/gelatin-allergies.html" target="_blank">http://www.chop.edu/service/vaccine-education-center/hot-topics/gelatin-allergies.html</a><br />
<br />
4. Centers       for Disease Control and Prevention, <u>Epidemiology and Prevention of       Vaccine-Preventable Diseases. (The Pink Book) </u>Atkinson, W., Hamborsky,       J., McIntyre, L., Wolfe, S. eds. 10th edition; Washington DE:       Public Health Foundation, 2008<br />
<br />
5. Centers       for Disease Control, Advisory Committee on Immunization Practices:       Publications-Recommendations, accessed 6/18/2008, <a href="http://www.cdc.gov/vaccines/pubs/ACIP-list.htm" target="_blank">http://www.cdc.gov/vaccines/pubs/ACIP-list.htm</a>.<br />
<br />
6. Centers       for Disease Control and Prevention, <u>Epidemiology and Prevention of       Vaccine-Preventable Diseases. (The Pink Book) </u>Atkinson, W., Hamborsky,       J., McIntyre, L., Wolfe, S. eds. 11th edition; Washington DE:       Public Health Foundation, 2009
<br />
<br />
7. Centers for Disease Control and Prevention, <u>Morbidity and Mortality        
      Weekly</u>, 59(90); 273, March 12, 2010.

<br />
<br />
8. Grabenstein, John D. <u>Immunofacts: Vaccines and Immunologic Drugs 2009.</u> St Louis, MO: Wolters Kluer Health, 2008.

<br />
<br />
9. Centers for Disease Control and Prevention, <u>Morbidity and Mortality Weekly</u>, 59(31); 989-992, August 13, 2010.

</blockquote>
<br />
<br />
<p  style="font-family:Arial; color:#58585a; font-size:10pt;">Approved by KFA's Medical Advisory Team January 2009.  Updated February 2010 and April 2011.</p></div>


</div>
</body>
</html>
